ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681633 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681633; 2) Community: the network communities that were significantly associated with the response to NSC 681633; 3) Molecule: the relationships between components within communities and NSC 681633; 4) MDR: the compounds that were significantly associated with the NSC 681633.

NSC Compound Enrichment Correlation
NSC 680553 2-Quinoxalinecarboxylic acid, 3-[(4-fluorophenyl)amino]-, ethyl ester 0.0193573267900282 0.10715091
NSC 685833 7H-Purine, 2,6-dichloro- 7-[2-deoxy-3,5-O-bis(4-methylphenyl)- .beta.-D-ribofuranosyl]- 0.020946768375828 0.1724161
NSC 10848 Null 0.0209467683758286 0.18178252
NSC 224131 N-Phosphonacetyl-L-aspartate 0.0209467683758286 0.41319309
NSC 319079 Null 0.0209467683758286 0.1544965
NSC 355461 B621099K443 0.0209467683758286 0.21538761
NSC 374028 Camptothecin Derivative 0.0209467683758286 0.91976839
NSC 38086 Null 0.0209467683758286 0.028125011
NSC 606498 Camptothecin Derivative 0.0209467683758286 0.79602862
NSC 609699 Topotecan hydrochloride 0.0209467683758286 0.92474562
Total:53  Current:22    [First] [Prev] [Next] [Last]